Biopharma startup

Oxford MEStar

Oxford MEStar is specialising in translational and regenerative medicine.

Funding reportedLast round: Grant

Biopharma

What company datasets say Oxford MEStar raised

Funding, as reported

Reported in all2.1Min the source's currency
Rounds3
Last roundGrant
Last round dateSept 2018
Investors listed1

Biopharma in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Oxford MEStar in front of investors. Or tell us what we have wrong.